Liora Lazar1, Joseph Meyerovitch, Liat de Vries, Moshe Phillip, Yael Lebenthal. 1. The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract
CONTEXT: Central precocious puberty (CPP), treated or untreated, may have implications in adulthood. OBJECTIVE: To assess the reproductive outcome and social adjustment of former CPP women between the 3rd and 5th decades of life. DESIGN: Cross-sectional study of an historical cohort. METHODS: Demographic data and gynaecological history of 214 CPP women aged 25-56 years [135 GnRH analogue (GnRHa)-treated, 18 cyproterone acetate (CyA)-treated, 61 untreated] and of 446 controls with normal puberty, matched for age and year of birth, were recorded in a structured interview. RESULTS: Marital status, education and number of children were similar in CPP women and controls. Clinical hyperandrogenism (acne/hirsutism with oligomenorrhoea) was more frequently reported in CPP women than in controls: GnRHa-treated 29·6% vs 17·4% (P = 0·006), CyA-treated 50% vs 20·4% (P = 0·04), untreated 34·4% vs 17·2% (P = 0·003), with no significant difference between CPP groups. Spontaneous pregnancy was similarly achieved by treated CPP and controls: GnRHa-treated 90·4% vs 93·4%, CyA-treated 86·7% vs 90·2%. Assisted fertilization rate was higher in untreated CPP than treated CPP groups (P = 0·006) and controls (P = 0·03). Untreated CPP was the only parameter associated with clinical hyperandrogenism (OR=2·04, 95% CI, 1·0-4·16, P = 0·07) and fertility problems (OR=3·40, 95% CI, 1·15-10·0, P = 0·047). Course of pregnancy was uneventful in 90·2% of CPP women and 90·9% of controls. CONCLUSIONS: The increased rate of clinical hyperandrogenism among CPP women implies that the underlying neuroendocrine dysfunction persists into adult life. Pubertal suppression treatment may have a protective effect as fertility problems were more prevalent only among untreated CPP women. Educational achievements and marital status were unaffected by CPP.
CONTEXT: Central precocious puberty (CPP), treated or untreated, may have implications in adulthood. OBJECTIVE: To assess the reproductive outcome and social adjustment of former CPP women between the 3rd and 5th decades of life. DESIGN: Cross-sectional study of an historical cohort. METHODS: Demographic data and gynaecological history of 214 CPP women aged 25-56 years [135 GnRH analogue (GnRHa)-treated, 18 cyproterone acetate (CyA)-treated, 61 untreated] and of 446 controls with normal puberty, matched for age and year of birth, were recorded in a structured interview. RESULTS: Marital status, education and number of children were similar in CPP women and controls. Clinical hyperandrogenism (acne/hirsutism with oligomenorrhoea) was more frequently reported in CPP women than in controls: GnRHa-treated 29·6% vs 17·4% (P = 0·006), CyA-treated 50% vs 20·4% (P = 0·04), untreated 34·4% vs 17·2% (P = 0·003), with no significant difference between CPP groups. Spontaneous pregnancy was similarly achieved by treated CPP and controls: GnRHa-treated 90·4% vs 93·4%, CyA-treated 86·7% vs 90·2%. Assisted fertilization rate was higher in untreated CPP than treated CPP groups (P = 0·006) and controls (P = 0·03). Untreated CPP was the only parameter associated with clinical hyperandrogenism (OR=2·04, 95% CI, 1·0-4·16, P = 0·07) and fertility problems (OR=3·40, 95% CI, 1·15-10·0, P = 0·047). Course of pregnancy was uneventful in 90·2% of CPP women and 90·9% of controls. CONCLUSIONS: The increased rate of clinical hyperandrogenism among CPP women implies that the underlying neuroendocrine dysfunction persists into adult life. Pubertal suppression treatment may have a protective effect as fertility problems were more prevalent only among untreated CPP women. Educational achievements and marital status were unaffected by CPP.
Authors: A D Fisher; J Ristori; E Bandini; S Giordano; M Mosconi; E A Jannini; N A Greggio; A Godano; C Manieri; C Meriggiola; V Ricca; D Dettore; M Maggi Journal: J Endocrinol Invest Date: 2014-05-27 Impact factor: 4.256
Authors: Amy C Tishelman; Randi Kaufman; Laura Edwards-Leeper; Francie H Mandel; Daniel E Shumer; Norman P Spack Journal: Prof Psychol Res Pr Date: 2015
Authors: Monica F Stecchini; Delanie B Macedo; Ana Claudia S Reis; Ana Paula Abreu; Ayrton C Moreira; Margaret Castro; Ursula B Kaiser; Ana Claudia Latronico; Sonir R Antonini Journal: Horm Res Paediatr Date: 2016-07-16 Impact factor: 2.852
Authors: Laetitia Martinerie; Jacques de Mouzon; Joelle Blumberg; Luigi di Nicola; Pascal Maisonobe; Jean-Claude Carel Journal: Horm Res Paediatr Date: 2021-03-26 Impact factor: 2.852
Authors: Ruben H Willemsen; Daniela Elleri; Rachel M Williams; Ken K Ong; David B Dunger Journal: Nat Rev Endocrinol Date: 2014-04-08 Impact factor: 43.330
Authors: Pierre Lemaire; Gwénaëlle Duhil de Bénazé; Dick Mul; Sabine Heger; Wilma Oostdijk; Raja Brauner Journal: PLoS One Date: 2018-10-09 Impact factor: 3.240